IP Library › Assignment 030038/0538
Patent Assignment
Reel/Frame 030038/0538

Change of Name

Recorded: 2013-03-19 Pages: 3
Assignor
N30 PHARMACEUTICALS, LLC
Executed: 2012-08-01
Assignee
N30 PHARMACEUTICALS, INC.
3122 STERLING CIRCLE, BOULDER, COLORADO, 80301
Covered Property (1)
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
Patent: 8,921,562 →
Application: 13/824,430 →
Publication: US 2013/0178499
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 19, 2013
From: SUN, XICHENG; QIU, JIAN; STOUT, ADAM
To: N30 PHARMACEUTICALS, LLC
Reel/Frame 030038/0531 →
Change of Name Mar 4, 2015
From: N30 PHARMACEUTICALS, INC.
To: NIVALIS THERAPEUTICS, INC.
Reel/Frame 035125/0164 →
Assignment of Assignor's Interest Jul 13, 2018
From: ALPINE IMMUNE SCIENCES, INC.
To: LAUREL VENTURE CAPITAL LTD.
Reel/Frame 046341/0795 →
Assignment of Assignor's Interest Apr 4, 2019
From: LAUREL VENTURE CAPITAL LTD.
To: LAUREL THERAPEUTICS LTD.
Reel/Frame 048787/0883 →